ClinicalTrials.gg
CompletedNCT01253993Updated Dec 6, 2010

Impaired Decision-making in Adolescents

An observational study in Adolescent Psychiatry, Antisocial Personality Disorders and Substance-Related Disorders, sponsored by UMC Utrecht. Completed at 1 site in Netherlands. Open to participants aged 14 Years to 21 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2010-12-06.

Sponsored by UMC Utrecht · Observational

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
152
Ages
14 Years to 21 Years
Sex
All
01

Study summary

There is clear evidence that aggressive behavior and disruptive behavior disorders (DBD) in middle childhood are associated with an increased risk for substance abuse in adolescence. However, the exact underlying mechanism of this increased risk is unknown. It is likely that a biopsychological vulnerability in some aggressive children and children with DBD makes them liable to substance use and abuse. The investigators hypothesize that deficient decision making is such a biopsychological factor. In this study the investigators aim to test the latter hypothesis by investigating the decision making ability in a group of adolescents with DBD with and without substance use disorders. Decision-making is assessed with the IOWA Gambling Task (GT). This task mimics real-life situations in the way it factors uncertainty, reward and punishment. The GT is specifically designed to assess impaired decision-making in individuals who are unable to learn from their mistakes and make decisions that repeatedly lead to negative consequences. This characteristic may be common to individuals with externalizing disorders such as DBD, psychopathy, and substance use disorders.

Read the detailed description

This study consists of two substudies with adolescents in the age of 14-21 years. The first study group consist of adolescents with DBD with (n=30) and without (n=30) substance use disorders. These adolescents are recruited from orthopsychiatric, forensic psychiatric, and judicial institutions.

The second study group consists of a) ex-patients of the Utrecht Coping Power Program (UCPP)who previously participated to a follow-up study, and b) ex-patients who were treated as a child at an outpatient clinic of the UMC Utrecht. These latter groups were taken together and subdivided into a group with (n=30) and without (n=30) substance use problems.

For both studies healthy controls (n=80) are recruited. The investigators will start with healthy controls from earlier studies, and those are extented and will serve as control group for both studies.

02

Conditions studied

  • Adolescent Psychiatry
  • Antisocial Personality Disorders
  • Substance-Related Disorders

Keywords

  • Disruptive Behavior Disorders, Substance abuse,
  • Iowa Gambling Task, Decision Making.
03

In context

Antisocial Personality Disorder

49 studies on the registry are indexed under Antisocial Personality Disorder; 8 are open to participants now.

This study's enrollment of 152 is below the median of 200 across 11 observational studies indexed under Antisocial Personality Disorder.

Browse Antisocial Personality Disorder studies →

Lead sponsor

UMC Utrecht is the lead sponsor of 363 studies on the registry; 81 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 21 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

DBD adolescents were recruited from judicial and forensic institutions. Healthy controls consisted of volunteers.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Having a DISC diagnosis DBD

Exclusion criteria

Exclusion Criteria:

  • Having the DISC diagnosis Schizophrenia
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
152 participants (actual)
06

Study locations

1 site
  • University Medical Center Utrecht
    Utrecht, Utrecht 3584 CX, Netherlands
07

References and documents

Publications

  • Ernst M, Grant SJ, London ED, Contoreggi CS, Kimes AS, Spurgeon L. Decision making in adolescents with behavior disorders and adults with substance abuse. Am J Psychiatry. 2003 Jan;160(1):33-40. doi: 10.1176/appi.ajp.160.1.33. PubMed 12505799 ↗
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Apr 2006, a primary completion of Jun 2007 and a completion of Sep 2007. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 2, 2007
First posted
Dec 6, 2010
Start
Apr 2006
Primary completionActual
Jun 2007
CompletionActual
Sep 2007
Last update
Dec 6, 2010
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 6, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01253993
Lead sponsor
UMC Utrecht
Collaborators
ZonMw: The Netherlands Organisation for Health Research and Development, National Institute on Drug Abuse (NIDA)
First posted
Dec 6, 2010
Start date
Apr 2006
Primary completion
Jun 2007
Completion
Sep 2007
Last update
Dec 6, 2010

Study contacts

Walter Matthys, MD, PhD
principal investigator · UMC Utrecht

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion